➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Medtronic
Johnson and Johnson
McKesson
Harvard Business School

Last Updated: May 8, 2021

DrugPatentWatch Database Preview

NOVOLOG MIX 70/30 FLEXPEN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for NOVOLOG MIX 70/30 FLEXPEN

Identify potential brand extensions & biosimilar entrants

SponsorPhase
University of Texas Southwestern Medical CenterPhase 4
Novo Nordisk A/SPhase 4

See all NOVOLOG MIX 70/30 FLEXPEN clinical trials

Recent Litigation for NOVOLOG MIX 70/30 FLEXPEN

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
NOVO NORDISK INC. v. SANDOZ INC.2020-06-04
Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.2017-03-03
Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.2017-03-02

See all NOVOLOG MIX 70/30 FLEXPEN litigation

PTAB Litigation
PetitionerDate
2014-01-23

See all NOVOLOG MIX 70/30 FLEXPEN litigation

Company Disclosures: US Patents for NOVOLOG MIX 70/30 FLEXPEN

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Novo Nordisk Inc NOVOLOG MIX 70/30 FLEXPEN insulin aspart protamine recombinant; insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 021172 004 2002-05-03   Get Started for $10 Novo Nordisk A/S (Basgsvaerd, DK) 2013-08-20 DISCN company
Novo Nordisk Inc NOVOLOG MIX 70/30 FLEXPEN insulin aspart protamine recombinant; insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 021172 004 2002-05-03   Get Started for $10 Novo Nordisk A/S (Bagsvaerd, DK) 2014-04-08 DISCN company
Novo Nordisk Inc NOVOLOG MIX 70/30 FLEXPEN insulin aspart protamine recombinant; insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 021172 004 2002-05-03   Get Started for $10 Novo Nordisk A/S (Bagsvaerd, DK) 2014-12-02 DISCN company
Novo Nordisk Inc NOVOLOG MIX 70/30 FLEXPEN insulin aspart protamine recombinant; insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 021172 004 2002-05-03   Get Started for $10 Novo Nordisk A/S (Bagsvaerd, DK) 2013-06-21 DISCN company
Novo Nordisk Inc NOVOLOG MIX 70/30 FLEXPEN insulin aspart protamine recombinant; insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 021172 004 2002-05-03   Get Started for $10 Novo Nordisk A/S (Bagsvaerd, DK) 2013-06-21 DISCN company
Novo Nordisk Inc NOVOLOG MIX 70/30 FLEXPEN insulin aspart protamine recombinant; insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 021172 004 2002-05-03   Get Started for $10 Novo Nordisk A/S (Bagsvaerd, DK) 2016-06-20 DISCN company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Supplementary Protection Certificates for NOVOLOG MIX 70/30 FLEXPEN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C990042 Netherlands   Get Started for $10 PRODUCT NAME: INSULIN ASPART; REGISTRATION NO/DATE: EU/1/99/119/001 - EU/1/99/119/005 19990907
300021 Netherlands   Get Started for $10 300021, 20140621, EXPIRES: 20150622
32/2000 Austria   Get Started for $10 PRODUCT NAME: INSULIN ASPART/PROTAMIN; NAT. REGISTRATION NO/DATE: EU/1/00/142/001-008 20000801; FIRST REGISTRATION: LI 55414-55416 20000623
SZ 40/2005 Austria   Get Started for $10 PRODUCT NAME: NOVOMIX 50 - SUSPENSION, ENTHALTEND LÖSLICHES INSULIN ASPART UND PROTAMINKRISTALLISIERTES INSULIN ASPART IM VERHÄLTNIS 50:50
132006901385692 Italy   Get Started for $10 PRODUCT NAME: SOSPENSIONE CONTENENTE INSULINA ASPART SOLUBILE E CRISTALLI DI INSULINA ASPART PROTOMINATA NEL RAPPORTO 50/50(NOVOMIX 50); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/00/142/011-012-013-014-015-016, 20051005
CA 2005 00046 Denmark   Get Started for $10 PRODUCT NAME: OPLOSELIGT INSULIN ASPART / PROTAMINKRYSTALLERET INSULIN ASPART 100E/ML I FORHOLDET 50/50
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
McKinsey
Merck
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.